Attributes | Values |
---|
rdf:type
| |
Description
| - The introduction of the calcineurin inhibitors (CI) cyclosporine and tacrolimus into immunosuppressive protocols initiated a new era in organ transplantation with excellent short-term graft survival. Nevertheless, the chronic nephrotoxicity of these drugs represents a significant adverse factor limiting their long-term use. Patients treated with a CI can be at risk for developing renal failure and this problem is especially pronounced in patients after renal transplantation. Over to their unique effects, CI remain the cornerstone of most immunosuppressive protocols for renat transplantation. Together with optimization of local kidney exposure to CI and their metabolities, efforts to reduce systemic levels as much as possible are the most important preventive measure for reducing toxic renal graft damage.
- The introduction of the calcineurin inhibitors (CI) cyclosporine and tacrolimus into immunosuppressive protocols initiated a new era in organ transplantation with excellent short-term graft survival. Nevertheless, the chronic nephrotoxicity of these drugs represents a significant adverse factor limiting their long-term use. Patients treated with a CI can be at risk for developing renal failure and this problem is especially pronounced in patients after renal transplantation. Over to their unique effects, CI remain the cornerstone of most immunosuppressive protocols for renat transplantation. Together with optimization of local kidney exposure to CI and their metabolities, efforts to reduce systemic levels as much as possible are the most important preventive measure for reducing toxic renal graft damage. (en)
|
Title
| - Calcineurin inhibitor-induced renal allograft nephrotoxicity
- Calcineurin inhibitor-induced renal allograft nephrotoxicity (en)
|
skos:prefLabel
| - Calcineurin inhibitor-induced renal allograft nephrotoxicity
- Calcineurin inhibitor-induced renal allograft nephrotoxicity (en)
|
skos:notation
| - RIV/61989592:15110/10:10213431!RIV11-MSM-15110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/10:10213431
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - prevention; risk factors; nephrotoxicity; renal allograft; cyclosporine and tacrolimus; calcineurin inhibitors (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Tichý, Tomáš
- Zadražil, Josef
- Krejčí, Karel
- Bachleda, Petr
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |